Evidence map›Paper›PMID 37630125›Full record

ArticleMicromachines2023

Biocompatible High-Resolution 3D-Printed Microfluidic Devices: Integrated Cell Chemotaxis Demonstration.

Mawla Boaks, Connor Roper, Matthew Viglione, Kent Hooper, Adam T Woolley, Kenneth A Christensen, Gregory P Nordin

Open access · goldAbstract read
In one paragraph

Article in Micromachines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Advances in Microengineered Platforms for Skin Research.JID innovations : skin science from molecules to population health · 2025
    Review
  8. Biomicrofluidics · 2024
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mawla BoaksDepartment of Electrical and Computer Engineering, Brigham Young University, Provo, UT 84602, USA.
Connor RoperDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Matthew ViglioneDepartment of Electrical and Computer Engineering, Brigham Young University, Provo, UT 84602, USA.ORCID 0000-0001-9744-0464
Kent HooperDepartment of Mechanical Engineering, Brigham Young University, Provo, UT 84602, USA.
Adam T WoolleyDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Kenneth A ChristensenDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.ORCID 0000-0002-3736-5500
Gregory P NordinDepartment of Electrical and Computer Engineering, Brigham Young University, Provo, UT 84602, USA.ORCID 0000-0001-7241-5764
Brigham Young University · US

Funding

High Density 3D Printed Microfluidics With Open Source Resins for Biomedical ApplicationsR15GM123405 · NIGMS · BRIGHAM YOUNG UNIVERSITY · PI NORDIN, GREGORY P. · 2017 to 2023
$1.3M
3D-Printed Integrated Microfluidic Devices for Preterm Birth Biomarker AnalysisR01EB027096 · NIBIB · BRIGHAM YOUNG UNIVERSITY · PI WOOLLEY, ADAM THOMAS · 2018 to 2021
$1.1M
NIBIB NIH HHS R01 EB027096NIBIB NIH HHS R01EB027096NIGMS NIH HHS R15 GM123405NIGMS NIH HHS R15GM123405
6 · The paper itself

Abstract

We demonstrate a method to effectively 3D print microfluidic devices with high-resolution features using a biocompatible resin based on avobenzone as the UV absorber. Our method relies on spectrally shaping the 3D printer source spectrum so that it is fully overlapped by avobenzone's absorption spectrum. Complete overlap is essential to effectively limit the optical penetration depth, which is required to achieve high out-of-plane resolution. We demonstrate the high resolution in practice by 3D printing 15 μm square pillars in a microfluidic chamber, where the pillars are separated by 7.7 μm and are printed with 5 μm layers. Furthermore, we show reliable membrane valves and pumps using the biocompatible resin. Valves are tested to 1,000,000 actuations with no observable degradation in performance. Finally, we create a concentration gradient generation (CG) component and utilize it in two device designs for cell chemotaxis studies. The first design relies on an external dual syringe pump to generate source and sink flows to supply the CG channel, while the second is a complete integrated device incorporating on-chip pumps, valves, and reservoirs. Both device types are seeded with adherent cells that are subjected to a chemoattractant CG, and both show clear evidence of chemotactic cellular migration. Moreover, the integrated device demonstrates cellular migration comparable to the external syringe pump device. This demonstration illustrates the effectiveness of our integrated chemotactic assay approach and high-resolution biocompatible resin 3D printing fabrication process. In addition, our 3D printing process has been tuned for rapid fabrication, as printing times for the two device designs are, respectively, 8 and 15 min.

Indexed as

3D printingbiocompatiblechemotaxisconcentration gradientintegrated chemotaxismicrofluidics

Identifiers

PMID37630125
PMCPMC10456398
OpenAlexW4385805897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.